showed that the circulating level of CD39+ Treg increased significantly in sepsis patients compared to patients with non-septic inflammation patients and healthy control subjects, suggesting that the frequency or MFI of CD39+ Treg may serve as a biomarker to predict the outcome of sepsis (29). Here, ENTPD1 is linked to Sepsis.